The total intrinsic value of stock options exercised for 2024, 2023 and 2022 was $
86
million, $
173
million and $
139
million, respectively. As of December 28, 2024, the Company had $
41
million of total unrecognized compensation expense related to stock options, which will be recognized over the weighted-average period of
2.71
years.
78
Table of Contents
Time-based RSUs.
The weighted-average grant date fair values of time-based RSUs granted during 2024, 2023 and 2022 were $
141.95
, $
106.28
and $
92.92
per share, respectively.
The following table summarizes time-based RSU activity and related information:
The total fair value of time-based RSUs vested during 2024, 2023 and 2022 was $
2.0
billion, $
1.1
billion and $
889
million, respectively. As of December 28, 2024, the Company had $
2.6
billion of total unrecognized compensation expense related to time-based RSUs, which will be recognized over the weighted-average period of
2.63
years.
PRSUs.
The weighted-average grant date fair values of PRSUs granted during 2024, 2023 and 2022 were $
118.98
, $
134.87
and $
121.12
, respectively, using the following assumptions:
The Company uses the historical volatility of its common stock and risk-free interest rate based on the rate for a U.S. Treasury zero-coupon yield curve with a term that approximates the expected life of the PRSUs grant at the date closest to the grant date. The expected dividend yield is
zero
as the Company does not expect to pay dividends in the near future. The expected term of PRSUs represents the requisite service periods of these PRSUs.
The following table summarizes PRSU activity and related information:
The total fair value of PRSUs vested during 2024, 2023 and 2022 was $
226
million, $
100
million and $
254
million, respectively. As of December 28, 2024, the Company had $
154
million of total unrecognized compensation expense related to PRSUs, which will be recognized over the weighted-average period of
1.61
years.
79
Table of Contents
ESPP.
The weighted-average grant date fair value for the ESPP during 2024, 2023 and 2022 was $
43.80
, $
31.11
and $
24.71
per share, respectively, using the following assumptions:
The Company uses the historical volatility of its common stock and the risk-free interest rate based on the rate for a U.S. Treasury zero-coupon yield curve with a term that approximates the expected life of the ESPP grant at the date closest to the ESPP grant date. The expected dividend yield is
zero
as the Company does not expect to pay dividends in the near future. The expected term of the ESPP represents the six-month offering period.
During 2024,
2
million shares of common stock were purchased under the ESPP at an average purchase price of $
111
resulting in aggregate cash proceeds of $
265
million. As of December 28, 2024, the Company had $
43
million of total unrecognized compensation expense related to the ESPP, which will be recognized over the weighted-average period of
0.37
years.
NOTE 13 –
Retirement